2nd International Conference and Exhibition on Nursing
November 19-21, 2018, San Diego , USA
Conference Updates
committee
Members
Rita M. Herm-Barabasz
Doctor of Nursing Practice
EDUCATION
University of Nevada, Las Vegas 2015, DNP, Doctor of Nursing Practice
School of Nursing
Las Vegas, NV
University of Illinois 2002, Acute Care Nurse Practitioner
College of Nursing Post-Master’s Degree Certification
Chicago, IL
DePaul University 1995, MSN, Nursing education emphasis
Chicago, IL
DePaul University 1987, BSN, Nursing emphasis
Chicago, IL
Illinois Masonic Medical Center 1983, Diploma in Nursing
School of Nursing
Chicago, IL
COMPLETED RESEARCH
Incidence of Acute Lower Extremity Venous Thrombosis after Percutaneous EVAR at Northwestern Memorial Hosptial 2015
Multicenter Prospective Randomized Controlled Trial of the Nitinol ZILVER Expandable Endoprosthesis in the Palliation of Extrahepatic Malignant Biliary Obstruction (MOZART I)
G.D. Searle and Company. Double-Blind, Placebo Controlled Randomized Comparison Study of the Efficacy and Upper Gastrointestinal Safety of 50 mg, 100 mg, and 200 mg SC-58635 BID and 500 mg Naproxen BID in treating the Signs and Symptoms of Osteoarthritis (021)
GD Searle and Company. Double-blind, Placebo Controlled Comparative Study of the Efficacy and Upper Gastrointestinal Safety of Arthrotec 75mg Twice Daily, Nabumetone 1500mg Daily and Naproxen 500mg Twice Daily in Treating the Signs and Symptoms of Osteoarthritis (355)
G.D. Searle and Company. Double-Blind, Placebo Controlled, Randomized Comparison Study of the Efficacy and Upper Gastrointestinal Safety of 100 mg, 200 mg and 400 mg SC-58635 BID and 500 mg Naproxen BID in treating the Signs and Symptoms of Rheumatoid Arthritis (022)
G.D. Searle and Company. Long-Term Safety of SC-58635 in Treating the Signs and Symptoms of Osteoarthritis and Rheumatoid Arthritis (024)
G.D. Searle and Company. Double-Blind, Parallel Group Study Comparing the Incidence of Gastroduodenal Ulcer Associated with SC-58635 200 mg BID with that of Naproxen 500 mg BID taken for 12 weeks in Patients with Osteoarthritis or Rheumatoid Arthritis (062)
G.D. Searle and Company. Double-Blind, Parallel Group Study Comparing the Incidence of Gastroduodenal Ulcer Associated with SC-58635 200 mg BID with that of Diclofenac 75 mg BID and Ibuprofen 800 mg TID, taken for 12 weeks in Patients with Osteoarthritis or Rheumatoid Arthritis (071)
G.D. Searle and Company. Clinical Protocol for a Multicenter, Double-Blind, Parallel Group Study Comparing the Incidence of Clinically Significant Upper Gastrointestinal Adverse Events Associated with SC-58635 400 mg BID to that of Ibuprofen 800 mg TID in Patients with Osteoarthritis or Rheumatoid Arthritis (035)
G.D. Searle and Company. Clinical Protocol for Multicenter, Double-Blind, Placebo-Controlled, Parallel Group Study Comparing the Incidence of Gastroduodenal Ulcer Associated with Valdecoxib 10 and 20 mg QD with that of Ibuprofen 800 mg TID and Diclofenac Sodium 75 mg BID taken for 12 weeks in Patients with Osteoarthritis (048)
Glaxo Wellcome Inc. Efficacy of Ranitidine Bismuth Citrate in Combination with Amoxicillin and Clarithromycin in Helicobactor pylori Eradication (RAC)
Glaxo Wellcome Inc. Efficacy of Ranitidine Bismuth Citrate in Combination with Clarithromycin and Metronidazole in Helicobacter pylori Eradication (RMC)
Wyeth-Ayerst. Comparison of the Clinical Safety and Efficacy of Pantoprazole 10 mg, 20 mg or 40 mg Once Daily and Placebo in Patients with Symptomatic Erosive Esophagitis
Astra Merck. Multicenter, Randomized, Double-Blind, Eight Week Comparative Efficacy and Safety Study of H 199/18 40 mg and Omeprazole 20 mg in Study Subjects with Erosive Esophagitis (174)
Astra Merck. Multicenter, Open-Label Long Term Safety Study of H 199/18 40 mg in Subjects with Healed Erosive Esophagitis (179)
Glaxo-Wellcome Inc. Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Alosetron in Female Subjects with Irritable Bowel Syndrome (IBS)
British Biotech. Double-Blind Randomized Placebo Controlled Multicenter Study to Evaluate the Efficacy and Safety of two Doses of Lexipafant for the Treatment of Acute Pancreatitis (D06/IVB/215)
British Biotech. Phase III, Double-Blind Randomized Placebo Controlled, Multicenter trial to Assess the Effect of Lexipafant on the Incidence of Acute Pancreatitis in Patients Undergoing an Endoscopic Retrograde Cholangiopancreatography (ERCP). (D06/IVB/221)
Jansen. Evaluation of the Use of Duragesic in Chronic Pancreatitis Patients with Chronic Pain.
Abbott Diagnostics, Inc. Abbott TestPak +Plus H. pylori COMBO rapid Immunoassay for Qualitative Detection of IgG to H. pylori in Serum
Bayer Diagnostics. Bayer H. pylori Assay for Qualitative Detection of IgG to H. pylori in Serum
Astra Pharmaceuticals. A Comparative Efficacy and Safety Study of H 199/18 (40 mg and Omeprazole (20 mg) in Study Subjects with Erosive Esophagitis. (222)
Wyeth-Ayerst. Comparison of the Clinical Efficacy and Safety of Pantoprazole 10 mg, 20 mg or 40 mg Once Daily and Ranitidine 150 mg BID as a Relapse prophylaxis Over Three Years for Patients with Healed Erosive Esophagitis Multicenter, prospective observational study of patients with acute Gastrointestinal Hemorrhage
Janssen. A Double-blind placebo-controlled Dose-finding Trial to Evaluate the Efficacy and Safety of R149524 in Diabetic Subjects with Symptoms of Gastroparesis
Tap Holdings. A study to Evaluate the Safety and Efficacy of TAK-637 (30mg BID, 60mg BID, and 120mg BID) versus Placebo in Subjects with Irritable Bowel Syndrome
G.D. Searle, Strange Cancer Institute & the National Cancer Institute. Prevention of Sporadic Colorectal Adenomas with Celecoxib (005)
Forrest Laboratories Inc. A 26-week, Randomized, Double-Blind, Active-Controlled, Multi-Center, Parrell Group Study to Investigate the Gastrointestinal Safety of ML3000 400 mg BID Compared to Naproxen 500 mg BID in Patients with Osteoarthritis (OA) of the Knee
Parmacia & Upjohn Company. Clinical Protocol for a Randomized, Double-Blind, Placebo Controlled, Parallel, Multiple Dose Comparison of the Effects of Celecoxib 200 mg BID and Placebo in Patients with Ulcerative Colitis in Remission.
EXACT Inc. A Multicenter Comparison of the EXACT Panel with Hemoccult II for the Detection of Colorectal Neoplasia in Average Risk Patients.
PROFESSIONAL SERVICES
2000 Two week Medical Mission to Zimbabwe, Africa. The clinic found in a rural area averaged 250 patients seen per day.
2009-present: Co-Program Director for the Annual Vascular Nursing Conference. Conference includes a full day, CEU provided, vascular lectures. As a program director I am responsible for lining up lecturers and content as well as obtaining Continuing Education Units. All coordinators/directors also give a presentation
PROFESSIONAL PRESENTATIONS
31th Annual Vascular Nursing Conference
Coordinator of Meeting and Content Presenter 11/2015
30th Annual Vascular Nursing Conference
Coordinator of Meeting and Content Presenter 11/2015
29th Annual Vascular Nursing Conference
Coordinator of Meeting and Content Presenter 11/2015
28th Annual Vascular Nursing Conference
Coordinator of Meeting and Content Presenter 11/2014
27th Annual Vascular Nursing Conference
Coordinator of Meeting and Content Presenter 10/2013
26th Annual Vascular Nursing Conference
Coordinator of Meeting and Content Presenter 10/2012
25th Annual Vascular Nursing Conference
Coordinator of Meeting and Content Presenter 10/2011
24rd Annual Vascular Nursing Conference
Coordinator of Meeting and Content Presenter 10/2010
23rd Annual Vascular Nursing Conference
Coordinator of Meeting and Content Presenter 10/2009
Cholesterol Embolizing Syndrome
28th Annual Vascular Nursing Conference 11/2014
HIT: Heparin Induced Thrombocytopenia
Multi unit In-services 2010/2013
Pulmonary Hygiene, Hospital Acquired Pneumonia in the Post-op Patient
23rd Annual Vascular Nursing Conference 10/2010
Thoracic Outlet Syndrome
23rd Annual Vascular Nursing Conference 10/2009
Pancreaticobiliary Disease in Everyday Practice
NPACE Conference October 2004
Colon Cancer and the Use of NSAIDs and COX-2 Inhibitors
Chicago SGNA Quarterly Meeting, 4/2000
Sponsor and Coordinator of meeting
Nursing Research Conference: Research into Practice; Issues, Approaches Outcomes
Two Open-Label Efficacy Trials of Ranitidine Bismuth Citrate in Combination with Clarithromysin and Amoxicillin or Metronidazole for H. pylori Eradication. Poster Presentation 2/2000
Mayo Clinic Rochester, Minnesota
Case Management in Home Care; Past, Present and Future
Governors State University, Sigma Theta Tau 4/1998
PUBLICATIONS
C. Daley, R. Herm-Barabasz, H. Rodriguez, A. Hoel and M. Eskandari. (May, 2015). Incidence of Acute Lower Extremity Venous Thrombosis after Percutaneous EVAR. Journal of Vascular Surgery, S0741-5214(15)00384-5.